These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8582487)

  • 1. [Mechanism of inhibition of aldosterone secretion by a Ca2+ channel blocker in patients with essential hypertension and patients with primary aldosteronism].
    Yokoyama T; Shimamoto K; Iimura O
    Nihon Naibunpi Gakkai Zasshi; 1995 Nov; 71(7):1059-74. PubMed ID: 8582487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationship of the renin-angiotensin-aldosterone system with auricular natriuretic factor in its response to the action of thiazide diuretics and to nifedipine, a sustained-release calcium antagonist].
    Ocón J; Mora-Macià J; Castellet R; del Río G
    Med Clin (Barc); 1994 Jan; 102(2):41-5. PubMed ID: 8133694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma renin activity and aldosterone concentration are not altered by the novel calcium channel antagonist, azelnidipine, in hypertensive patients.
    Kondo T; Goto R; Sonoda K; Yasuda T; Ono K; Takaki Y; Yatsuda R; Miyamura N; Araki E
    Intern Med; 2010; 49(7):637-43. PubMed ID: 20371952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term modulation of the renin-angiotensin system does not alter plasma adrenomedullin concentration in humans.
    Kita T; Kitamura K; Kuwasako K; Kawamoto M; Eto T
    J Hypertens; 1998 Dec; 16(12 Pt 2):2057-62. PubMed ID: 9886897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pressor agents on blood pressure, plasma renin activity and plasma aldosterone concentration in essential hypertension.
    Yamamoto Y
    Jpn Heart J; 1975 Jul; 16(4):404-20. PubMed ID: 1152295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sodium balance and calcium channel-blocking drugs on plasma aldosterone responses to infusion of angiotensin II in normal subjects and patients with essential hypertension.
    Anderson GH; Howland T; Domschek R; Streeten DH
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1126-35. PubMed ID: 3760114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are calcium antagonists helpful in the management of primary aldosteronism?
    Stimpel M; Ivens K; Wambach G; Kaufmann W
    J Cardiovasc Pharmacol; 1988; 12 Suppl 6():S131-4. PubMed ID: 2468897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic value of calcium antagonists in autonomous hyperaldosteronism.
    Stimpel M; Ivens K; Volkmann HP; Wambach G; Kaufmann W
    Klin Wochenschr; 1989 Feb; 67(4):248-52. PubMed ID: 2648061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nifedipine does not blunt the aldosterone and cardiovascular response to angiotensin II and potassium infusion in hypertensive patients.
    Terzoli L; Leonetti G; Pedretti R; Bragato R; Sampieri L; Fruscio M; Boselli L; Zanchetti A
    J Cardiovasc Pharmacol; 1988 Mar; 11(3):317-20. PubMed ID: 2452924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of idiopathic hyperaldosteronism with normal plasma aldosterone concentrations for 5 years after onset: a 12-year follow-up study].
    Nemoto T; Niimura S; Hayashi A; Gomibuchi T; Sanada H; Watanabe Y; Shigetomi S; Fukuchi S
    Nihon Naibunpi Gakkai Zasshi; 1994 May; 70(4):439-46. PubMed ID: 7958093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of angiotensin II and potassium in the long-term regulation of aldosterone secretion in intact conscious dogs.
    McCaa RE; McCaa CS; Guyton AC
    Circ Res; 1975 Jun; 36(6 Suppl 1):57-67. PubMed ID: 1132083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute dopaminergic inhibition of aldosterone secretion is independent of angiotensin II and adrenocorticotropin.
    Carey RM
    J Clin Endocrinol Metab; 1982 Feb; 54(2):463-9. PubMed ID: 6274907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism.
    Mizuno K; Yamazaki M; Ikeda K; Yaginuma K; Hashimoto S; Fukuchi S
    Jpn Heart J; 1983 Nov; 24(6):917-24. PubMed ID: 6323781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of upright posture on the aldosterone responses to dopamine, metoclopramide, angiotensin II, and adrenocorticotropin.
    Malchoff CD; Hughes JM; Carey RM
    J Clin Endocrinol Metab; 1987 Jul; 65(1):203-7. PubMed ID: 3034955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of trilostane, a new inhibitor of adrenal steroid biosynthesis, on blood pressure, plasma aldosterone and other steroid hormones, serum potassium and plasma renin activity in primary aldosteronism (author's transl)].
    Shigetomi S; Fukuchi S; Haruyama K; Yamazaki M
    Nihon Naibunpi Gakkai Zasshi; 1982 Mar; 58(3):184-98. PubMed ID: 6212269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of spironolactone on fluid volumes and adrenal steroids in primary aldosteronism.
    Ichikawa S; Tajima Y; Sakamaki T; Matsuo H; Kogure M; Hirano Y; Yagi S; Murata K
    Jpn Circ J; 1984 Nov; 48(11):1184-96. PubMed ID: 6502914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The clinical use of captopril in the diagnosis and treatment of primary aldosteronism].
    Li J
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Feb; 18(1):2-4, 60. PubMed ID: 2204520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma aldosterone concentration is associated with white matter lesions in patients with primary aldosteronism.
    Yuan Y; Li N; Liu Y; Wang M; Heizhati M; Zhu Q; Yao X; Luo Q
    Endocrine; 2022 Mar; 75(3):889-898. PubMed ID: 34780033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin receptor blockade lowers plasma aldosterone levels via different mechanisms in primary aldosteronism and high-to-normal renin hypertension.
    Rossi GP; Ganzaroli C; Cesari M; Maresca A; Plebani M; Nussdorfer GG; Pessina AC
    Cardiovasc Res; 2003 Jan; 57(1):277-83. PubMed ID: 12504838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.